Citius Pharmaceuticals Inc

CTXR NASDAQ
1.080
+0.010
+0.00%
After Hours: 1.080 0 0.00% 16:47 08/22 EDT
Open
1.080
Prev Close
1.080
High
1.100
Low
1.074
Volume
8.03K
Avg Vol (3M)
87.26K
52 Week High
2.520
52 Week Low
0.8582
% Turnover
0.04%
Market Cap
23.84M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Citius Pharmaceuticals Inc CTXR stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of critical care products targeting medical needs with a focus on anti-infective products, adjunctive cancer care, and prescription products. Its product candidates include Mino-Lok and Hydrocortisone-Lidocaine Cream. The Company's Mino-Lok is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter. The Company's Hydrocortisone-Lidocaine topical formulation provides anti-inflammation and anesthetic relief to persons suffering from hemorrhoids. Its Mino-Lok product for the treatment of catheter related bloodstream infections has completed Phase IIb and is entering Phase III trials. It is reformulating Hydrocortisone-Lidocaine product and will be entering Phase IIb trials in 2017. As of September 30, 2016, the Company had not generate any revenues.
MORE >

Recently

Name
Price
%Change